Open access · CC-BY
via OpenAlex
Protein Aggregation as a Bacterial Strategy to Survive Antibiotic Treatment
Celien Bollen, Liselot Dewachter, Jan Jacques Michiels
Frontiers in Molecular Biosciences · 2021 · ▲ 67 citations
Abstract
While protein aggregation is predominantly associated with loss of function and toxicity, it is also known to increase survival of bacteria under stressful conditions. Indeed, protein aggregation not only helps bacteria to cope with proteotoxic stresses like heat shocks or oxidative stress, but a growing number of studies suggest that it also improves survival during antibiotic treatment by inducing dormancy. A well-known example of dormant cells are persisters, which are transiently refractory to the action of antibiotics. These persister cells can switch back to the susceptible state and resume growth in the absence of antibiotics, and are therefore considered an important cause of recurrence of infections. Mounting evidence now suggests that this antibiotic-tolerant persister state is tightly linked to-or perhaps even driven by-protein aggregation. Moreover, another dormant bacterial phenotype, the viable but non-culturable (VBNC) state, was also shown to be associated with aggregation. These results indicate that persisters and VBNC cells may constitute different stages of the same dormancy program induced by progressive protein aggregation. In this mini review, we discuss the relation between aggregation and bacterial dormancy, focusing on both persisters and VBNC cells. Understanding the link between protein aggregation and dormancy will not only provide insight into the fundamentals of bacterial survival, but could prove highly valuable in our future battle to fight them.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fmolb.2021.669664
- Canonical
- link ↗
- Fetched
- 2026-10-01 MST
Cite this
APA
Bollen, C., Dewachter, L., & Michiels, J.J. (2021). Protein Aggregation as a Bacterial Strategy to Survive Antibiotic Treatment. <em>Frontiers in Molecular Biosciences</em>. https://doi.org/10.3389/fmolb.2021.669664
Vancouver
Bollen C, Dewachter L, Michiels JJ. Protein Aggregation as a Bacterial Strategy to Survive Antibiotic Treatment. Frontiers in Molecular Biosciences. 2021. doi:10.3389/fmolb.2021.669664.
BibTeX
@article{celien2021Protei,
title = {Protein Aggregation as a Bacterial Strategy to Survive Antibiotic Treatment},
author = {Celien Bollen and Liselot Dewachter and Jan Jacques Michiels},
journal = {Frontiers in Molecular Biosciences},
year = {2021},
doi = {10.3389/fmolb.2021.669664},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
mBio 2021
Open access · CC-BY
The Dynamic Transition of Persistence toward the Viable but Nonculturable State during Stationary Phase Is Driven by Protein Aggregation
Genes & Development 2019
Preprint · CC-BY
Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells
Annals of Neurology 2003
Citation only
Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease
Biology of Reproduction 2018
Citation only
Effects of prostaglandin E2 on gap junction protein alpha 1 in the rat epididymis†
2025
Open access · OA
Bloodletting (blood donation) as a possible method of rejuvenation of the body
RNA Biology 2026
Open access · CC-BY